Resources
38 Results (showing 11 - 20)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 7/13/2020 (updated 3/28/2024)
In Minnesota, American Indians have five to six times the opioid overdose death rate of other groups—the largest such disparity in the United States. This webinar occurred on July 10, 2020.
Posted 6/30/2020 (updated 3/28/2024)
This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.
Posted 6/16/2020 (updated 3/28/2024)
This cross-sectional study included all counties and county-equivalent divisions in the US in 2016. Data on racial/ethnic population distribution were derived from the American Community Survey, and data on locations of facilities providing methadone and buprenorphine were obtained from Substance Abuse and Mental Health Services Administration databases.
Posted 6/15/2020 (updated 3/28/2024)
The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.
Posted 8/24/2020 (updated 3/28/2024)
Lessons Learned From Listening Sessions With Five Tribes in Minnesota.
Posted 4/16/2020 (updated 3/28/2024)
… the care they need. Discover how you can help reduce stigma among all moms and babies so they can get the support … toolkit is designed to raise awareness about the impact of stigma, encourage accurate & non-stigmatizing language, … … Neonatal opioid withdrawal (NOWS) … addicted baby … Anti-Stigma Toolkit for Women & Babies …
Posted 8/24/2020 (updated 3/28/2024)
Medications for opioid use disorder, including buprenorphine hydrochloride and methadone hydrochloride, are highly effective at improving outcomes for individuals with the disorder. For pregnant women, use of these medications also improves pregnancy outcomes, including the risk of preterm birth. Despite the known benefits of medications for opioid use disorder, many pregnant and nonpregnant women with the disorder are not receiving them.
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Mint Room on Wednesday, March 5, 2020, at 2:30 PM
Posted 7/24/2020 (updated 3/28/2024)
The IHS forensic healthcare program was established in 2011 to address sexual violence, and has expanded to include intimate partner violence, child sexual abuse, and elder maltreatment. The program trains providers in forensic medical examinations, evidence collection techniques, and in coordinated community response to address violence.
Posted 7/17/2020 (updated 3/28/2024)
Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infants. Studies using administrative data have estimated that 14%–22% of women filled a prescription for opioids during pregnancy; however, data on self-reported prescription opioid use during pregnancy are limited.